Showing results (1931-1940 of 1,981) with videos related to
Sort By:
Pageof 199
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virusLiang Yu, Zhaoming Wang, Yu Chen, et al.Blood|April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A Parikh, Kari G Rabe, Neil E Kay, et al.The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|May 4, 2021
Toxicokinetic and Genotoxicity Study of NNK in Male Sprague Dawley Rats Following Nose-Only Inhalation Exposure, Intraperitoneal Injection, and Oral GavageShu-Chieh Hu, Matthew S Bryant, Estatira Sepehr, et al.Cell Regeneration (London, England)|March 24, 2025
Standard: human liver-on-a-chipHaitao Liu, Xu Zhang, Yaqing Wang, et al.Blood|January 9, 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signatureSalma B Abdelbaky, Brian Giacopelli, Kari G Rabe, et al.Pageof 199